Amyotrophic lateral sclerosis pathoetiology and pathophysiology: roles of astrocytes, gut microbiome, and muscle interactions via the mitochondrial melatonergic …

G Anderson - International Journal of Molecular Sciences, 2022‏ - mdpi.com
The pathoetiology and pathophysiology of motor neuron loss in amyotrophic lateral sclerosis
(ALS) are still to be determined, with only a small percentage of ALS patients having a …

Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics

D Yadav, P Kumar - Neurochemistry international, 2022‏ - Elsevier
Neurotransmitters are considered as a fundamental regulator in the process of neuronal
growth, differentiation and survival. Parkinson's Disease (PD) occurs due to extensive …

Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillation

JC Lal, C Mao, Y Zhou, SR Gore-Panter… - Cell Reports …, 2022‏ - cell.com
Effective drugs for atrial fibrillation (AF) are lacking, resulting in significant morbidity and
mortality. This study demonstrates that network proximity analysis of differentially expressed …

Current drug repurposing strategies for rare neurodegenerative disorders

S Shah, MM Dooms, S Amaral-Garcia… - Frontiers in …, 2021‏ - frontiersin.org
Rare diseases are life-threatening or chronically debilitating low-prevalent disorders caused
by pathogenic mutations or particular environmental insults. Due to their high complexity …

Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis

W Zhou, R Xu - Frontiers in Neuroscience, 2023‏ - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease
that leads to the massive loss of motor neurons in cerebrum, brain stem and spinal cord. It …

[HTML][HTML] Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases

W Bild, A Vasincu, RN Rusu, DC Ababei, AB Stana… - Biomolecules, 2022‏ - mdpi.com
Brain neurodegenerative diseases (BND) are debilitating conditions that are especially
characteristic of a certain period of life and considered major threats to human health …

The landscape of the methodology in drug repurposing using human genomic data: a systematic review

L Wang, Y Lu, D Li, Y Zhou, L Yu… - Briefings in …, 2024‏ - academic.oup.com
The process of drug development is expensive and time-consuming. In contrast, drug
repurposing can be introduced to clinical practice more quickly and at a reduced cost. Over …

Network medicine informed multiomics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral Sclerosis

M Yu, J Xu, R Dutta, B Trapp, AA Pieper… - NPJ Systems Biology and …, 2024‏ - nature.com
Abstract Amyotrophic Lateral Sclerosis (ALS) is a devastating, immensely complex
neurodegenerative disease by lack of effective treatments. We developed a network …

[HTML][HTML] In silico drug repurposing in COVID-19: A network-based analysis

P Sibilio, S Bini, G Fiscon, M Sponziello, F Conte… - Biomedicine & …, 2021‏ - Elsevier
The SARS-CoV-2 pandemic is a worldwide public health emergency. Despite the beginning
of a vaccination campaign, the search for new drugs to appropriately treat COVID-19 …

Integrating transcriptomic and structural insights: revealing drug repurposing opportunities for sporadic ALS

N Sunildutt, F Ahmed, AR Chethikkattuveli Salih… - ACS …, 2024‏ - ACS Publications
Amyotrophic lateral sclerosis (ALS) is a progressive and devastating neurodegenerative
disorder characterized by the loss of upper and lower motor neurons, resulting in debilitating …